1-5 of 5
Authors: Addison Barnett
Sort by
Journal Article
THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS Open Access
Addison Barnett and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.056
Published: 12 August 2019
Journal Article
THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS Open Access
Soumya Sagar and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i11, https://doi.org/10.1093/noajnl/vdz014.045
Published: 12 August 2019
Journal Article
THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES Open Access
Adam Lauko and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i12, https://doi.org/10.1093/noajnl/vdz014.052
Published: 12 August 2019
Journal Article
THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES Open Access
Adam Lauko and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i12–i13, https://doi.org/10.1093/noajnl/vdz014.053
Published: 12 August 2019
Journal Article
THER-16. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS Open Access
Addison Barnett and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i14, https://doi.org/10.1093/noajnl/vdz014.059
Published: 12 August 2019
Advertisement
Advertisement